Publikationen in Zusammenarbeit mit Forschern von Kiel University (33)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

    Clinical Gastroenterology and Hepatology, Vol. 21, Núm. 3, pp. 771-788.e10

  3. Sarcopenic obesity research perspectives outlined by the sarcopenic obesity global leadership initiative (SOGLI) – Proceedings from the SOGLI consortium meeting in rome November 2022

    Clinical Nutrition

2022

  1. Genetic variants associated with longitudinal changes in brain structure across the lifespan

    Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

    European Journal of Immunology, Vol. 51, Núm. 12, pp. 2708-3145

  3. Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

    Nature Communications, Vol. 12, Núm. 1

  4. Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 51-58

  5. Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels

    Alimentary Pharmacology and Therapeutics, Vol. 54, Núm. 8, pp. 999-1012

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  2. MDS evidence-based review of treatments for essential tremor

    Movement Disorders, Vol. 34, Núm. 7, pp. 950-958

2018

  1. CD9 controls integrin α5β1-mediated cell adhesion by modulating its association with the metalloproteinase ADAM17

    Frontiers in Immunology, Vol. 9, Núm. NOV

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. Transducer-based evaluation of tremor

    Movement Disorders, Vol. 31, Núm. 9, pp. 1327-1336

2015

  1. Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015

    Cell Death and Differentiation, Vol. 22, Núm. 1, pp. 58-73

2014

  1. Hypermethylation of the alternative AWT1 promoter in hematological malignancies is a highly specific marker for acute myeloid leukemias despite high expression levels

    Journal of Hematology and Oncology, Vol. 7, Núm. 1

  2. Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions

    New England Journal of Medicine, Vol. 370, Núm. 12, pp. 1101-1110